BGI Genomics Co., Ltd. (SHE:300676)

BGI Genomics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	3,898	3,935	4,732	5,160	6,590	5,430
Short-Term Investments	-	17.17	23.28	11.2	6.57	-
Trading Asset Securities	415.42	375.12	753.58	1,232	2,049	-
Cash & Short-Term Investments	4,313	4,327	5,509	6,403	8,646	5,430
Cash Growth	-18.01%	-21.46%	-13.96%	-25.94%	59.22%	345.99%
Accounts Receivable	1,692	1,679	1,464	2,223	1,244	1,576
Other Receivables	85.47	73.24	54.22	174.47	49.74	117.01
Receivables	1,778	1,752	1,518	2,397	1,294	1,693
Inventory	572.44	601.62	602.18	717.83	877.72	1,010
Other Current Assets	224.81	194.9	303.49	257.24	217.2	284.31
Total Current Assets	6,888	6,876	7,933	9,775	11,035	8,417
Property, Plant & Equipment	2,886	2,854	3,190	2,191	1,400	1,287
Long-Term Investments	1,305	1,306	1,252	1,328	898.21	449.29
Goodwill	36.47	36.47	47.11	47.11	47.11	47.11
Other Intangible Assets	343.06	359.6	418.82	410.89	245.46	146.76
Long-Term Deferred Tax Assets	244.78	230.47	241.58	236.29	200.29	162.06
Long-Term Deferred Charges	303.34	299.14	362.86	209.51	177.65	95.89
Other Long-Term Assets	588.32	580.15	167.17	187.25	250.86	589.6
Total Assets	12,595	12,542	13,613	14,385	14,254	11,195
Accounts Payable	808.22	1,137	864.6	1,025	805.32	873.23
Accrued Expenses	95.76	798.56	668.29	958.97	653.08	963.13
Short-Term Debt	24.32	24.91	-	-	5.01	563.3
Current Portion of Long-Term Debt	-	31.23	24.18	-	35.74	23.7
Current Portion of Leases	-	26.32	57.79	63.33	90.6	-
Current Income Taxes Payable	31.08	12.7	59.79	77.35	167.83	147.02
Current Unearned Revenue	604.17	637.83	699.71	929.35	1,410	840.88
Other Current Liabilities	849.9	173.59	922.68	901.93	216.41	390.86
Total Current Liabilities	2,413	2,842	3,297	3,956	3,384	3,802
Long-Term Debt	842.87	339.11	215.68	-	631.96	658
Long-Term Leases	61.51	49.7	67.75	136.68	84.44	73.89
Long-Term Unearned Revenue	30.59	15.11	15.39	19.68	36.07	49.1
Long-Term Deferred Tax Liabilities	11.76	24.89	13.13	51.56	5.19	1.48
Other Long-Term Liabilities	-	-	-	-	671.57	584.7
Total Liabilities	3,360	3,271	3,609	4,164	4,813	5,169
Common Stock	415.82	415.82	413.91	413.91	413.91	400.1
Additional Paid-In Capital	4,789	4,762	4,592	4,680	4,657	2,605
Retained Earnings	3,829	3,882	4,826	5,147	4,488	3,160
Treasury Stock	-99.92	-99.92	-115.32	-336.75	-87.95	-175.89
Comprehensive Income & Other	167.28	175.21	143.11	172	-152.57	-78.61
Total Common Equity	9,101	9,135	9,859	10,076	9,318	5,910
Minority Interest	134.36	136.75	144.78	145.09	122.87	115.64
Shareholders' Equity	9,235	9,272	10,004	10,221	9,441	6,026
Total Liabilities & Equity	12,595	12,542	13,613	14,385	14,254	11,195
Total Debt	928.7	471.27	365.4	200.01	847.75	1,319
Net Cash (Debt)	3,385	3,856	5,144	6,203	7,798	4,111
Net Cash Growth	-31.76%	-25.05%	-17.07%	-20.46%	89.68%	256.96%
Net Cash Per Share	8.19	9.35	12.47	15.12	18.94	10.30
Filing Date Shares Outstanding	412.32	412.38	379.44	409.91	409.91	396.09
Total Common Shares Outstanding	412.32	412.38	379.44	409.91	409.91	396.09
Working Capital	4,475	4,034	4,636	5,819	7,651	4,615
Book Value Per Share	22.07	22.15	25.98	24.58	22.73	14.92
Tangible Book Value	8,721	8,739	9,393	9,618	9,026	5,716
Tangible Book Value Per Share	21.15	21.19	24.76	23.46	22.02	14.43
Buildings	-	1,782	1,787	490.05	418.81	422.23
Machinery	-	2,362	2,195	1,841	1,612	1,635
Construction In Progress	-	205.67	418.08	752.33	38.5	53.4

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.